The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
Open accessAbstract
Objective: Studies of subjects with dementia of the Alzheimer type have reported correlations between increases in activity of the hypothalamic-pituitary-adrenal (HPA) axis and hippocampal degeneration. In this study, the authors sought to determine whether increases in plasma cortisol, a marker of HPA activity, were associated with clinical and cognitive measures of the rate of disease progression in subjects with Alzheimer-type dementia. Method: Thirty-three subjects with very mild and mild Alzheimer-type dementia and 21 subjects without dementia were assessed annually for up to 4 years with the Clinical Dementia Rating scale and a battery of neuropsychological tests. Plasma was obtained at 8 a.m. on a single day and assayed for cortisol. Rates of change over time in the clinical and cognitive measures were derived from growth curve models. Results: In the subjects with dementia, but not in those without dementia, higher plasma cortisol levels were associated with more rapidly increasing symptoms of dementia and more rapidly decreasing performance on neuropsychological tests associated with temporal lobe function. No associations were observed between plasma cortisol levels and clinical and cognitive assessments obtained at the single assessment closest in time to the plasma collection. Conclusions: Higher HPA activity, as reflected by increased plasma cortisol levels, is associated with more rapid disease progression in subjects with Alzheimer-type dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“African Americans are also the most religious ethnic group in society [413]”
From Religion, Spirituality, and Health: The Research and Clinical Implications (2012) · cites this paper as [413]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and validation of a geriatric depression screening scale: a preliminary report
Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982) · Journal of Psychiatric Research · doi:10.1016/0022-3956(82)90033-4 · Cited by 15,025
Littell, R. C. (1996) · Medical Entomology and Zoology · Cited by 10,345
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationRandom-Effects Models for Longitudinal Data
Laird, N. M., & Ware, J. H. (1982) · Biometrics · doi:10.2307/2529876 · Cited by 8,923
Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
Mapelli, D., Rosa, E. D., Nocita, R., & Sava, D. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353457 · Cited by 3,477
An active and socially integrated lifestyle in late life might protect against dementia
Fratiglioni, L., Paillard-Borg, S., & Winblad, B. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00767-7 · Cited by 2,135
Hippocampal atrophy in recurrent major depression
Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932
Self-citationMild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,871
Self-citationMcEwen, B. S. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02950-4 · Cited by 1,827
JACOBSON, L., & SAPOLSKY, R. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-118 · Cited by 1,739
Cited by
Sorted by citations
Items 201–300 of 426
Steroid and nonsteroidal anti-inflammatory drugs, cognitive decline, and dementia
Ancelin, M., Carrière, I., Helmer, C., Rouaud, O., Pasquier, F., Berr, C., Chaudieu, I., & Ritchie, K. A. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.038 · Cited by 31
Central CRF system perturbation in an Alzheimer's disease knockin mouse model
Guo, Q., Zheng, H., & Justice, N. J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.01.002 · Cited by 31
LAM, L. C. W., Tam, C. W. C., Lui, V. W.-C., Chan, W. C., Chan, S. S. M., Ho, K. S., Chan, W. M., & Chiu, H. F. K. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181631517 · Cited by 30
Longitudinal associations between diurnal cortisol variation and later-life cognitive impairment
Tsui, A., Richards, M., Singh‐Manoux, A., Udeh‐Momoh, C. T., & Davis, D. H. J. (2019) · Neurology · doi:10.1212/wnl.0000000000008729 · Cited by 28
Definitions and Concepts of Stress
Manosso, L. M., Gasparini, C. R., Réus, G. Z., & Pavlovic, Z. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_2 · Cited by 33
Craig, L. A., Hong, N. S., Kopp, J., & McDonald, R. J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06179.x · Cited by 29
“Interestingly, elevated cortisol levels have been found in patients with AD; with higher levels correlating with more severe dementia and increased hippocampal atrophy (Davis et al., 1986; Csernansky et al., 2006).”
BackgroundDobarro, M., Orejana, L., Aguirre, N., & Ramírez, M. J. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712001393 · Cited by 29
Midlife Neuroticism and the age of onset of Alzheimer's disease
Archer, N. J., Brown, R. G., Reeves, S., Nicholas, H., Boothby, H., & Lovestone, S. (2008) · Psychological Medicine · doi:10.1017/s003329170800408x · Cited by 31
“Perhaps consistent with this, higher levels of blood cortisol have been associated with faster cognitive decline in the context of dementia (Csernansky et al. 2006).”
BackgroundDijckmans, B., Tortosa‐Martínez, J., Pertegáz, N. C. I., González-Caballero, G., Martínez-Pelegrin, B., Manchado, C., Cortell-Tormo, J. M., Chulvi‐Medrano, I., & Clow, A. (2017) · European Review of Aging and Physical Activity · doi:10.1186/s11556-017-0175-5 · Cited by 28
Gai, Z., Su, D., Wang, Y., Li, W., Cui, B., Li, K., She, X., & Wang, R. (2017) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-017-0686-8 · Cited by 28
Bacopamonnieri (L.) exerts anti-inflammatory effects on cells of the innate immune system in vitro
Williams, R. P. W., Münch, G. W., Gyengési, E., & Bennett, L. E. (2014) · Food & Function · doi:10.1039/c3fo60467e · Cited by 32
dos Santos, A. T., Leyendecker, D. D., Costa, A. L. S., & Souza‐Talarico, J. N. (2012) · Revista da Escola de Enfermagem da USP · doi:10.1590/s0080-62342012000700004 · Cited by 28
Cabral, J. C. C., Veleda, G. W., Mazzoleni, M., Colares, E. P., Neiva-Silva, L., & das Neves, V. T. (2016) · Ciência & Saúde Coletiva · doi:10.1590/1413-812320152111.17452015 · Cited by 34
Rasmuson, S., Näsman, B., & Olsson, T. (2011) · International Psychogeriatrics · doi:10.1017/s1041610211000810 · Cited by 27
“No association between longitudinal and cross-sectional findings could be demonstrated in one study (Swanwick et al., 1998), but other studies have reported that increasing levels of glucocorticoids correlate to disease stage (Umegaki et al., 2000; Csernansky et al., 2006).”
ResultTortosa‐Martínez, J., & Clow, A. (2012) · Stress · doi:10.3109/10253890.2011.629323 · Cited by 29
Meco, A. D., Joshi, Y. B., Lauretti, E., & Praticò, D. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.78 · Cited by 27
The relationship between cortisol and verbal memory in the early stages of Huntington’s disease
Shirbin, C. A., Chua, P. M.-L., Churchyard, A., Hannan, A. J., Lowndes, G., & Stout, J. C. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6732-y · Cited by 26
Tamano, H., Kan, F., Oku, N., & Takeda, A. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.08.013 · Cited by 26
Association between Autoimmune Rheumatic Diseases and the Risk of Dementia
Lu, K., Wang, H., Yeh, C., Huang, C., Sung, P., Wang, L., Muo, C., Sung, F.-C., Chen, H., Li, Y.-C., et al. (2014) · BioMed Research International · doi:10.1155/2014/861812 · Cited by 26
Self-citationLi, W., Li, W., Zhang, W., Yin, Y., Sun, X., Zhou, S., Xu, X., & Tao, C. (2011) · The Anatomical Record · doi:10.1002/ar.21386 · Cited by 26
“Also, plasma levels of the stress hormone, cortisol, are correlated with the rate of dementia progression in patients with AD (Csernansky et al., 2006).”
BackgroundEnvironmental novelty exacerbates stress hormones and Aβ pathology in an Alzheimer’s model
Stuart, K., King, A., Fernandez-Martos, C. M., Summers, M., & Vickers, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03016-0 · Cited by 22
Lesuis, S. L., van Hoek, B. A. C. E., Lucassen, P. J., & Krugers, H. J. (2017) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2017.05.016 · Cited by 27
“For example, stress exposure has been associated with an increased incidence of AD and AD pathology in humans and rodents (Aznar & Knudsen, 2011; Csernansky et al., 2006; Green, Billings, Roozendaal, McGaugh, & LaFerla, 2006; Hoogendijk, Meynen, Endert, Hofman, & Swaab, 2006; Huang et al., 2009;…”
BackgroundThe fibroblast growth factor system in cognitive disorders and dementia
Zhai, W., Zhang, T., Jin, Y., Huang, S., Xu, M., & Pan, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1136266 · Cited by 31
Lenze, E. J., Dixon, D. J., Mantella, R. C., Doré, P., Andreescu, C., Reynolds, C. F., Newcomer, J. W., & Butters, M. A. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2732 · Cited by 26
“Many causes of cognitive impairment in late‐life anxiety disorders, such as underlying neurodegenerative disease due to Alzheimer’s disease pathology, may involve the HPA axis but not be remediable (Csernansky et al., 2006; Lind et al., 2007).”
BackgroundDong, H., Keegan, J., Hong, E. S., Gallardo, C., Montalvo‐Ortiz, J. L., Wang, B., Rice, K. C., & Csernansky, J. G. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.02.013 · Cited by 26
Self-citationWhite, S., Mauer, R., Lange, C., Klimecki, O., Huijbers, W., Wirth, M., & Initiative, A. D. N. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12463 · Cited by 28
Circadian rhythm of brain‐derived neurotrophic factor in serum and plasma
Ehrhardt, M., Schreiber, S., Duderstadt, Y., Braun-Dullaeus, R. C., Borucki, K., Brigadski, T., Müller, N. G., Leßmann, V., & Müller, P. (2024) · Experimental Physiology · doi:10.1113/ep091671 · Cited by 26
Glucocorticoid may influence amyloid β metabolism in patients with depression
Ishijima, S., Baba, H., Maeshima, H., Shimano, T., Inoue, M., Suzuki, T., & Arai, H. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.10.008 · Cited by 24
Overexpression of SIRT1 Inhibits Corticosterone-Induced Autophagy
Jiang, Y., Botchway, B. O. A., Hu, Z., & Fang, M. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.05.035 · Cited by 26
Taylor, G. T., Maloney, S. E., Dearborn, J. T., & Weiss, J. (2009) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152409789630398 · Cited by 23
Takeda, A., & Tamano, H. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.06.021 · Cited by 24
Cortisol: Mediator of association between Alzheimer’s disease and diabetes mellitus?
Notarianni, E. L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.04.008 · Cited by 23
Cortisol associated with hypometabolism across the Alzheimer’s disease spectrum
Wirth, M., Lange, C., Huijbers, W., & Initiative, F. T. A. D. N. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.003 · Cited by 23
Chronic Stress and Alzheimers Disease-Like Pathogenesis in a Rat Model: Prevention by Nicotine
Alkadhi, K. A. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376307 · Cited by 23
Neuroimmunomodulatory steroids in Alzheimer dementia
Hampl, R., & Bičı́ková, M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.007 · Cited by 23
Chronic stress and Alzheimer's disease
Mohammadi, S., Zandi, M., Kataj, P. D., & Karimi‐Zandi, L. (2021) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2216 · Cited by 22
Resilience, Stress, and Cortisol Predict Cognitive Performance in Older Adults
Sáez-Sanz, N., Peralta‐Ramírez, M. I., González-Pérez, R., Vázquéz-Justo, E., & Caracuel, A. (2023) · Healthcare · doi:10.3390/healthcare11081072 · Cited by 22
The effect of stress on the expression of the amyloid precursor protein in rat brain
Sayer, R., Robertson, D., Balfour, D. J. K., Breen, K. C., & Stewart, C. A. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.11.032 · Cited by 22
Knockout of 5‐lipoxygenase prevents dexamethasone‐induced tau pathology in 3xTg mice
Joshi, Y. B., Chu, J., & Praticò, D. (2013) · Aging Cell · doi:10.1111/acel.12096 · Cited by 22
“AD patients display higher levels of circulating glucocorticoids than age-matched controls, and higher levels of glucocorticoids confer greater risk of developing dementia in cognitively intact aged persons (Csernansky et al., 2006; Wilson et al., 2006; Huang et al., 2009).”
BackgroundLenze, E. J., Hershey, T. G., Newcomer, J. W., Karp, J. F., Blumberger, D. M., Anger, J. T., Doré, P., & Dixon, D. J. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4085 · Cited by 23
“…and decline in older adults (Lupien et al., 1994; Lupien et al., 1998; Lupien et al., 1999; O’Brien et al., 2004; Karlamangla et al., 2005; Csernansky et al., 2006; Fiocco et al., 2006; Li et al., 2006; Lee et al., 2007; Lind et al., 2007; Yehuda et al., 2007; Gerritsen et al., 2011;…”
BackgroundTamano, H., Ide, K., Adlard, P. A., Bush, A. I., & Takeda, A. (2016) · The Journal of Toxicological Sciences · doi:10.2131/jts.41.449 · Cited by 22
Takeda, A., Tamano, H., Nishio, R., & Murakami, T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071149 · Cited by 25
Perez‐Nievas, B. G., Hammerschmidt, T., Kummer, M. P., Terwel, D., Leza, J. C., & Heneka, M. T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07083.x · Cited by 21
“(2011) 116, 43–52 mented elevated plasma cortisol levels in individuals suffering from dementia or AD (Hartmann et al. 1997; Weiner et al. 1997; Peskind et al. 2001; de Bruin et al. 2002; Csernansky et al. 2006).”
BackgroundRole of the gut microbiome in Alzheimer’s disease
Chok, K. C., Ng, K. Y., Koh, R. Y., & Chye, S. M. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0122 · Cited by 22
Hypothalamus and amyotrophic lateral sclerosis: potential implications in sleep disorders
Gnoni, V., Zoccolella, S., Giugno, A., Urso, D., Tamburrino, L., Filardi, M., & Logroscino, G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1193483 · Cited by 22
Reyna, N. C., Clark, B. J., Hamilton, D. A., & Pentkowski, N. S. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1251075 · Cited by 21
Güldiken, S., & Güldiken, B. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.05.036 · Cited by 20
Effect of cortisol levels on working memory performance in elderly subjects with Alzheimer's disease
Souza‐Talarico, J. N., Caramelli, P., Nitríni, R., & Chaves, E. C. (2008) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2008000500003 · Cited by 20
Muntsant-Soria, A., & Giménez‐Llort, L. (2021) · Biomedicines · doi:10.3390/biomedicines9070715 · Cited by 21
Saiyasit, N., Butlig, E.-A. R., Chaney, S. D., Traylor, M. K., Hawley, N. A., Randall, R. B., Bobinger, H. V., Frizell, C. A., Trimm, F., Crook, E. D., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.915405 · Cited by 22
Bellaire, S., Walzer, M., Wang, T., Krauwinkel, W. J. J., Yuan, N., & Marek, G. J. (2019) · Clinical and Translational Science · doi:10.1111/cts.12618 · Cited by 19
Puccio, S., Chu, J., & Praticò, D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015163 · Cited by 19
Glucocorticoid Therapy is Associated with a Lower Risk of Dementia
Nerius, M., Haenisch, B., Gomm, W., Doblhammer, G., & Schneider, A. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190444 · Cited by 19
Potvin, O., Forget, H., Préville, M., Berbiche, D., Chagnon, Y. C., & Hudon, C. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212001706 · Cited by 18
“It was also reported that morning plasma cortisol was associated with faster cognitive decline in elders with Alzheimer’s disease (Csernansky et al., 2006).”
BackgroundSouza‐Talarico, J. N., Chaves, E. C., Nitríni, R., & Caramelli, P. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000259696 · Cited by 18
Lara, V. P., Caramelli, P., Teixeira, A. L., Barbosa, M. T., Carmona, K. C., Guimarães, H. C., Ferriani, M. D. G. C., Fernandes, A. P., & Gomes, K. B. (2015) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21865 · Cited by 18
Relationship between cortisol, Interleukin-6 and homocysteine in Alzheimer's disease
Yeram, N., Dalvi, S. M., Mankeshwar, R., Patil, V. W., Kale, V. P., Jagiasi, K., & Abichandani, L. G. (2021) · Qatar medical journal · doi:10.5339/qmj.2021.33 · Cited by 17
Pentkowski, N. S., Bouquin, S. J., Maestas-Olguin, C. R., Villasenor, Z. M., & Clark, B. J. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113661 · Cited by 18
Sex-dependent effects of acute stress on amyloid-β in male and female mice
Edwards, H. M., Wallace, C. E., Gardiner, W. D., Doherty, B. M., Harrigan, R. T., Yuede, K. M., Yuede, C. M., & Cirrito, J. R. (2023) · Brain · doi:10.1093/brain/awad052 · Cited by 24
Xu, H., Hu, W., Zhang, X., Gao, W., Liang, M., Chen, T., He, X., & Hu, Z. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2011.07.010 · Cited by 17
Bini, J., Bhatt, S., Hillmer, A. T., Gallezot, J., Nabulsi, N., Pracitto, R., Labaree, D. C., Kapinos, M., Ropchan, J. R., Matuskey, D., et al. (2020) · Molecular Imaging and Biology · doi:10.1007/s11307-020-01490-z · Cited by 19
Intact circadian rhythm despite cortisol hypersecretion in Alzheimer’s disease: A meta-analysis
Saelzler, U. G., Verhaeghen, P., Panizzon, M. S., & Moffat, S. D. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105367 · Cited by 17
Lee, B., Sur, B., Cho, S., Yeom, M., Shim, I., Lee, H., & Hahm, D. (2015) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.027 · Cited by 17
Leiva, R., Griñán‐Ferré, C., Seira, C., Valverde, E., McBride, A., Binnie, M., Pérez, B., Luque, F. J., Pallàs, M., Bidon‐Chanal, A., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.08.003 · Cited by 19
Harris, B. N., Roberts, B. R., DiMarco, G. M., Maldonado, K. A., Okwunwanne, Z., Savonenko, A. V., & Soto, P. L. (2022) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2022.114126 · Cited by 19
Shorey, C. L., Mulla, R. T., & Mielke, J. G. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148157 · Cited by 19
Li, W., Li, W., Huang, D., Kan, H., Wang, X., Wu, W., Yin, Y., & Yao, Y. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.038 · Cited by 16
Nguyen, E. T., Selmanovic, D., Maltry, M., Morano, R. L., Franco, A. C. G., Estrada, C. M., & Solomon, M. B. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104852 · Cited by 18
Trait anxiety, a personality risk factor associated with Alzheimer’s Disease
Li, S., Wang, C., Wang, W., & Tan, J. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110124 · Cited by 21
Depression and Dementia: The Role of Cortisol and Vascular Brain Lesions. AGES-Reykjavik Study
Gerritsen, L., Twait, E. L., Jónsson, P. V., Gudnason, V. G., Launer, L. J., & Geerlings, M. I. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215241 · Cited by 16
Endocrine dysfunction and cognitive impairment
Calsolaro, V., Bottari, M., Coppini, G., Lemmi, B., & Monzani, F. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.20.03295-2 · Cited by 16
Ribes, D., Torrente, M., Vicens, P., Colomina, M. T., Gómez, M., & Domingo, J. L. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182211ab1 · Cited by 17
Chronic psychosocial stress exposes Alzheimer s disease phenotype in a novel at-risk model
Karim, A. A. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/371 · Cited by 18
Palpatzis, E., Akinci, M., Dominguez, P. A., García-Prat, M., Blennow, K., Zetterberg, H., Carboni, M., Kollmorgen, G., Wild, N., Fauria, K., et al. (2024) · Annals of Neurology · doi:10.1002/ana.26881 · Cited by 17
Souza‐Talarico, J. N., Alves, A. R., Brucki, S. M. D., Nitríni, R., LUPIEN, S. J., & Suchecki, D. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104601 · Cited by 15
Ding, S., Liu, Y., Huang, L., Kong, L., Chen, M., Su, Y., Li, X., Dong, X., Han, Y., Li, W., et al. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113407 · Cited by 15
Alkadhi, K. A., & Tran, T. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8839-x · Cited by 15
Management of obesity in the elderly: Too much and too late?
Kennedy, R. L., Malabu, U. H., Kazi, M., & Shahsidhar, V. (2008) · The journal of nutrition health & aging · doi:10.1007/bf03008271 · Cited by 15
Stress, health and ageing: a focus on postmenopausal women
Wolf, O. T., & Kudielka, B. M. (2008) · Menopause international · doi:10.1258/mi.2008.008021 · Cited by 15
Gandy, H. M., Hollis, F., Hernandez, C. M., & McQuail, J. A. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1306496 · Cited by 13
Zhong, X.-M., Ning, Y.-P., Gu, Y., Wu, Z.-Y., Ouyang, C., Liang, W., Chen, B., Peng, Q., Mai, N., Wu, Y., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.07.052 · Cited by 13
Shen, S., Cheng, J., Li, J., Xie, Y., Wang, L., Zhou, X., Zhou, W., Zhu, L., Wang, T., Tu, J., et al. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-04159-9 · Cited by 15
Self-citationAliev, G. M., Ashraf, G. M., Kaminsky, Y. G., SHEIKH, I. A., Sudakov, S. K., Yakhno, N. N., Benberin, V. V., & Бачурин, С. О. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513504614 · Cited by 14
“Increased levels of cortisol and activity of the hypothalamic pituitary axis are seen with rapid cognitive decline in dementia.(54) Among the various emotional problems, depression, anxiety, anger, apathy, and fear are commonly encountered in patients with dementia and depression.”
BackgroundTamano, H., Yusuke, E., Ide, K., & Takeda, A. (2016) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.16-0028 · Cited by 14
Levels of Cortisol in CSF Are Associated With SNAP-25 and Tau Pathology but Not Amyloid-β
Wang, Q., Zhou, W., Zhang, J., & Initiative, T. A. D. N. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00383 · Cited by 14
Unwind: Chronic Stress Exacerbates the Deficits of Alzheimer's Disease
Alberini, C. M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.001 · Cited by 14
Hendrickx, J. O., Moudt, S. D., Calus, E., Martinet, W., Guns, P., Roth, L., Deyn, P. P. D., Dam, D. V., & Meyer, G. R. Y. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136656 · Cited by 13
Stress and HPA Axis Dysfunction in Alzheimer’s Disease
Joshi, Y. B., & Praticò, D. (2013) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-62703-598-9_11 · Cited by 13
Gómez-Gallego, M., & Gómez-García, J. (2018) · Aging & Mental Health · doi:10.1080/13607863.2018.1506741 · Cited by 13
Karlamangla, A. S., Almeida, D. M., Lachman, M. E., Merkin, S. S., Thomas, D., & Seeman, T. E. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105804 · Cited by 13
Duarte-Zambrano, F., Barrero, J. A., & Mockus, I. (2023) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2023-0031 · Cited by 12
Meng, F., Zhao, J., Fang, H., Zhang, L., Wu, H., & Liu, Y.-J. (2017) · Behavior Genetics · doi:10.1007/s10519-017-9843-5 · Cited by 13
BACE1 as an early biomarker and its relevance to risk factors for Alzheimer’s disease
Ohno, M. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111475 · Cited by 12
Effects of stress on emotional memory in patients with Alzheimer's disease and in healthy elderly
Gómez-Gallego, M., & Gómez-García, J. (2017) · International Psychogeriatrics · doi:10.1017/s1041610217002642 · Cited by 11
Suhr, J. A., Demireva, P., & Heffner, K. L. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.07.007 · Cited by 11
Ho, R., Fong, T. C. T., Yau, J. C. Y., Chan, W. C., Kwan, J. S. K., Chiu, P. K. C., & LAM, L. C. W. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00035 · Cited by 13
Gregory, S., Denham, S. G., Lee, P. J., Simpson, J. P., & Homer, N. Z. M. (2023) · Metabolites · doi:10.3390/metabo13020265 · Cited by 10
Lei, Y., Nougaisse, J., Malek, M., Mishu, M. M., Bai, Y., Denney, K., Du, Q., Stranahan, A. M., Garza, J. C., & Lu, X. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03067-0 · Cited by 15
Targeting Glucocorticoid Receptors: A New Avenue for Alzheimer’s Disease Therapy
Canet, G., Chevallier, N., Perrier, V., Desrumaux, C. M., & Givalois, L. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_15 · Cited by 10
Feasibility of Hair Cortisol as a Biomarker of Chronic Stress in People With Dementia
Kim, E., Bolkan, C. R., Crespi, E. J., & Madigan, J. (2022) · Biological Research For Nursing · doi:10.1177/10998004221090468 · Cited by 10
Metadata
- Authors
- Csernansky, J. G., Dong, H., Fagan, A. M., Wang, L., Xiong, C., Holtzman, D. M., & Morris, J. C.
- Affiliations
- Washington University in St. Louis (US)
- Venue
- American Journal of Psychiatry
- Published
- 2006-12
- Volume
- 163
- Issue
- 12
- Pages
- 2164-2169
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC1780275
- OpenAlex
- W2079409065
- Cited by
- 426
- References
- 54
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 15 · 2023: 20 · 2022: 19 · 2021: 28 · 2020: 28 · 2019: 27 · 2018: 30 · 2017: 19 · 2016: 27 · 2015: 30 · 2014: 22 · 2013: 16 · 2012: 21
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG 025824, AG20794, AG03991, AG 05681, R01AG025824, P50AG005681, P01AG003991)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer-type dementia, plasma cortisol, hypothalamic-pituitary-adrenal axis, disease progression, hippocampal neurodegeneration, cognitive decline, Clinical Dementia Rating, growth curve models
- MeSH terms
- Age Factors, Aged, Alzheimer Disease, Cognition Disorders, Female, Humans, Hydrocortisone, Longitudinal Studies, Male, Psychiatric Status Rating Scales, Severity of Illness Index, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review